when should i take my bpc 157 Protecting and Repairing the Body with BPC-157 The Truth About BPC 157

Dosing Schedules from Published Research Phase 2 Trial Dose Groups The Phase 2 clinical trial published in NEJM employed the following dose groups, all administered via subcutaneous injection once weekly: Scroll sideways to view the full table on mobile

Unfortunately, current recommendations preclude the administration of the herpes zoster vaccine, a live vaccine, to patients receiving biologic therapy, so it would be reasonable to consider giving this vaccine prior to initiating treatment

Once you know your form you need to consider which delivery method is best suited to you as there are also options here

Haematological parameters typically normalise within approximately 8 weeks of appropriate treatment